⚡ NeuroBand - The TENS-Integrated Smart Shorts & Waistband for Back Pain & Sciatica Relief

The Concept in One Line

Take the "TENS electrode built into period underwear" idea - and apply it to everyday shorts or a waistband that delivers targeted electrical nerve stimulation directly to the lower back and sciatic nerve pathway, invisible, wearable, always-on.

The Problem

• ~619 million people globally suffer from low back pain (WHO, 2023)
• Sciatica affects 10-40% of the population at some point in their life
• Current solutions are fragmented: bulky TENS units with sticky electrode pads, back braces that only compress, or pills with side effects
• People have to manually apply electrode patches every session - messy, time-consuming, they fall off during movement

The Innovation: What Makes It New

Core Technical Layers

OUTER LAYER  →  Breathable, stretch athletic fabric (looks like normal shorts/waistband)
MIDDLE LAYER →  E-textile conductive pathways (silver-coated nylon threads)
               Pre-mapped electrode zones at:
               • Lumbar spine (L3, L4, L5 vertebral level)
               • Gluteus / piriformis (sciatic nerve root)
               • Optional: hamstring/calf pathway for full sciatica coverage
INNER LAYER  →  Moisture-wicking skin-contact layer with hydrogel-infused zones
               (replaces traditional TENS gel pads)
CONTROL UNIT →  Small, detachable Bluetooth module (snap-on at waistband, ~thumb-sized)
               Rechargeable via USB-C, removable for washing

Clinical Evidence Behind It

• A 2026 network meta-analysis (Wang et al., Ann Phys Rehabil Med, PMID: 41275581) found TENS and interferential current significantly reduce chronic low back pain - with specific optimal frequencies identified (80-100 Hz for high-frequency TENS)
• A WHO-commissioned 2023 systematic review (Verville et al., PMID: 37991646) reviewed TENS for chronic primary low back pain and identified clear benefit profiles
• A 2023 systematic review on peripheral nerve stimulation for low back pain (D'Souza et al., PMID: 37060395) confirmed non-invasive nerve stimulation is effective and safe for chronic LBP
• A 2024 systematic review (Eid et al., PMID: 38926726) expanded evidence to transcutaneous vagus nerve stimulation showing systemic pain modulation effects

How It Works (User Experience)

1. Put it on - wear NeuroBand shorts or waistband like regular underwear/activewear
2. Open the app - select your pain profile (acute flare, chronic dull ache, sciatica, post-workout)
3. Auto-calibrate - device detects skin contact from conductive zones and sets baseline impedance
4. Therapy starts - delivers pulsed electrical stimulation (1-150 Hz range) to pre-mapped lumbar and sciatic zones
5. Wear during your day - sitting, walking, working - not just lying on a bed like traditional TENS
6. Track progress - app logs pain scores, session duration, relief patterns over time

Product Line

Innovation Differentiators (Patent-Worthy Angles)

1. Anatomically pre-mapped electrode zones sewn into garment at clinically validated lumbar nerve pathway positions - no user placement required
2. Hydrogel-infused inner fabric eliminates the need for traditional TENS electrode gel while remaining washable
3. Impedance-sensing auto-calibration - the module detects skin contact quality and adjusts output automatically
4. AI-adaptive stimulation profiles - learns user's pain patterns via app and adjusts frequency/intensity over time
5. Detachable modular control unit - the garment itself is washable; the electronics snap off in seconds

Market Opportunity

• Global back pain management market: $12.8 billion (2024), growing at 6.2% CAGR
• Global wearable medical device market: $46 billion (2025)
• TENS device market: $1.8 billion (2024) - still dominated by traditional sticky-pad devices
• Target early adopters: office workers (desk-related back pain), physiotherapy patients, athletes, pregnant women, elderly with chronic sciatica

Closest Competitors & Why NeuroBand is Different

• Quell (NeuroMetrix) - worn on the calf, targets central pain via peroneal nerve; not lumbar-specific, not a garment
• iReliev / TENS 7000 - traditional clip-on TENS units; still require manual pad placement
• Comfortisse / Physicool back braces - compression only, no electrotherapy
• Myovolt - vibration therapy in a waistband, not electrical nerve stimulation
• myfibra (Instagram startup, 2026) - women's reproductive health smart underwear, confirms the category is emerging

Go-To-Market Path

• Seek FDA 510(k) clearance as Class II medical device (predicate: existing wearable TENS units)
• Partner with physiotherapy clinics for trial data
• CE mark for EU market

• Direct-to-consumer via website and Amazon
• Target physiotherapists as referral channel
• Subscription model: replacement hydrogel-fabric inner liners (monthly)

• License the electrode-textile technology to sportswear brands (Nike, Under Armour integration)
• Sell data insights (anonymized pain patterns) to insurers and pharma
• Expand to knee, shoulder, neck variants using same platform

The Pitch Summary

TENS therapy has decades of clinical evidence behind it for back pain and sciatica. The only reason millions of people don't use it daily is because current devices are inconvenient - sticky pads, trailing wires, a box you clip to your belt. NeuroBand makes the garment the device. Put on your shorts, open an app, and your therapy happens while you live your life. It is the same conceptual leap that period pain TENS wearables made for women's health - applied to the largest pain management market in the world.

• A product vision mockup showing what NeuroBand shorts/waistband looks like?
• An investor pitch slide deck (.pptx) expanding on this concept?
• A market sizing infographic for the back pain wearable space?